Steward Partners Investment Advisory, LLC Genprex, Inc. Transaction History

Steward Partners Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.21 - $2.7 $1,815 - $4,050	-1,500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.66 - $7.67 $1,830 - $3,835	500 Added 50.0%	1,500 $6,000
Q1 2020 Apr 29, 2020	BUY	$0.28 - $6.23 $280 - $6,230	1,000 New	1,000 $2,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.